Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ( SEBI Listing Regulations )
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma's Board has approved the appointment of Suresh Surana & Associates LLP (Indian affiliate of global network RSM International) as Statutory Auditors for a five-year term, from the conclusion of the 5th AGM until the 10th AGM in 2030. The Board also appointed N L Bhatia & Associates, Practising Company Secretaries, as Secretarial Auditors for a similar five-year period. Both appointments are subject to shareholder approval at the upcoming AGM. This appears to be a routine transition of auditors at the end of the current term cycle, given the company was incorporated in 2020.
This is a routine corporate governance update with no material impact on shareholders or stock price. Suresh Surana & Associates LLP brings the backing of a large global audit network (RSM International, ranked 6th globally), which may strengthen audit quality and credibility.